Cardiol Therapeutics Inc banner

Wall St Price Targets

CT9 Price Forecast
Based on 5 analysts

+443% Upside
from €0.897 today

Cardiol Therapeutics Inc (CT9)’s 12-month stock price forecast through November 2027 has a consensus target of €4.871, implying 443% upside. The forecast is based on price targets from 5 Wall Street analysts.

CT9 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for CT9 yet.

Cardiol Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CT9's stock price target?
Price Target
4.871 EUR

According to Wall Street analysts, the average 1-year price target for CT9 is 4.871 EUR with a low forecast of 4.674 EUR and a high forecast of 5.169 EUR.

Back to Top